Crossmark

Comparison of charges and resource use associated with saxagliptin and sitagliptin

Crossref DOI link: https://doi.org/10.1186/s13561-016-0104-8

Published Online: 2016-07-07

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vaidya, Varun

Adhikari, Keyuri

Sheehan, Jack

Kalsekar, Iftekhar
Funding

Funding for this research was provided by:

AstraZeneca
License Information

Text and Data Mining valid from 2016-07-07
More Information

Article History

Received: 22 January 2016

Accepted: 15 June 2016

First Online: 7 July 2016